Post-partum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment
Hauser, I.; Schneider, B.; Lechner, K.
Thrombosis and Haemostasis 73(1): 1-5
1995
ISSN/ISBN: 0340-6245 PMID: 7740477 Document Number: 444491
In a retrospective study 51 published cases of post-partum factor VIII inhibitors were analyzed with regard to the outcome according to treatment. The overall outcome was favorable with 97% survival at two years. The probability of complete remission (CR, absence of the inhibitor and normalization of factor VIII activity) was almost 100% at 30 months. Steroid treatment appears to be not superior to no treatment, but patients treated with immunosuppressive drugs (cyclophosphamide, azathioprine, 6-mercaptopurine) had a significantly shorter time to CR. In the absence of a randomized trial this analysis may be helpful for decision-making in women with factor VIII post-partum inhibitors. Because of the retrospective study design, conclusions have to be regarded with caution.